OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
August 02, 2022
Experts divulge where the industry is outsourcing most frequently, when companies should outsource more, and when performing tasks in-house might be best.
July 27, 2022
WuXi STA is opening a new large-scale oligonucleotide and peptide manufacturing facility.
June 29, 2022
MilliporeSigma and Lotte Group will collaborate on facility design and workforce training for a new biologics business unit in the US.
June 10, 2022
Astellas Pharma has opened its new gene therapy manufacturing facility in Sanford, NC, which will support clinical- and commercial-scale manufacturing of AAV vectors for gene therapies.
The expansion at Seqirus’ Holly Springs, N.C., manufacturing facility will support the formulation and fill/finish of influenza vaccines.
June 02, 2022
Advances in genomics tools can lead to quicker biotherapeutic development.
May 26, 2022
Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.
AGC Biologics is investing in viral vector suspension technology at its new Longmont, Colo., facility.
May 11, 2022
Further development of nucleic acid-based therapeutics has been accelerated by the recent success of mRNA vaccines.
May 02, 2022
Complex hurdles complicate the development of emerging therapies.